Collaboration underscores both companies’ commitment to advancing patient-centric solutions and expanding access to therapies through novel drug delivery technologies Under the terms of the agreement, ...
The MarketWatch News Department was not involved in the creation of this content. CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable") a healthcare innovation company ...
CINCINNATI, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® on-body drug delivery system, announced ...
The MarketWatch News Department was not involved in the creation of this content. Enable Injections Announces Agreement with Sobi(R) to Develop and Distribute Aspaveli(R) in Combination with enFuse(R) ...
CINCINNATI and HUNTSVILLE, Alabama, May 15, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug ...
CINCINNATI, Feb. 7, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse ® platform of wearable drug delivery systems, today ...
(RTTNews) - Healthcare innovation company Enable Injections, Inc. and biotechnology company Swedish Orphan Biovitrum AB or Sobi, announced Thursday an international development and distribution ...
CINCINNATI, Feb. 14, 2024 /PRNewswire/ -- Enable Injections, Inc. ("Enable"), a leading innovator in developing and manufacturing the enFuse ® platform of wearable technology, today announced it plans ...
Aptar Digital Health Enable Injections Inc. enFuse Digital Companion Solution Through this partnership, Aptar Digital Health ...
CINCINNATI, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse ® wearable drug delivery platform, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results